These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25069814)

  • 1. Short-term venous stasis induces fibrinolytic activation but not thrombin formation.
    Rühl H; Müller J; Wäschenbach J; Oldenburg J; Dewald O; Pötzsch B
    J Atheroscler Thromb; 2014; 21(12):1260-70. PubMed ID: 25069814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with everolimus is associated with a procoagulant state.
    Baas MC; Gerdes VE; Ten Berge IJ; Heutinck KM; Florquin S; Meijers JC; Bemelman FJ
    Thromb Res; 2013 Aug; 132(2):307-11. PubMed ID: 23906938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia.
    Colucci M; Simioni P; Piro D; Prandoni P; Pagnan A; Semeraro N
    Haematologica; 2003 Dec; 88(12):1383-9. PubMed ID: 14687992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hormone-associated resistance to activated protein C on the thrombotic potential of oral contraceptives: a prospective observational study.
    Rühl H; Schröder L; Müller J; Sukhitashvili S; Welz J; Kuhn WC; Oldenburg J; Rudlowski C; Pötzsch B
    PLoS One; 2014; 9(8):e105007. PubMed ID: 25121606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
    Joly B; Barbay V; Borg JY; Le Cam-Duchez V
    Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
    Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood coagulation and fibrinolysis in arteriosclerosis].
    Hoffmeister HM; Heller W; Seipel L
    Z Kardiol; 1999 May; 88(5):315-23. PubMed ID: 10413853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature.
    Douketis JD; Gordon M; Johnston M; Julian JA; Adachi JR; Ginsberg JS
    Thromb Res; 2000 Jul; 99(1):25-34. PubMed ID: 11012376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostasis activation in thrombophilic subjects with or without a history of venous thrombosis.
    Cuderman TV; Bozic M; Peternel P; Stegnar M
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):55-62. PubMed ID: 17895509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Silence Speaks, but We Do Not Listen: Synonymous c.1824C>T Gene Variant in the Last Exon of the Prothrombin Gene as a New Prothrombotic Risk Factor.
    Pruner I; Farm M; Tomic B; Gvozdenov M; Kovac M; Miljic P; Soutari NMH; Antovic A; Radojkovic D; Antovic J; Djordjevic V
    Clin Chem; 2020 Feb; 66(2):379-389. PubMed ID: 32040579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of the APTT- and ETP-based APC sensitivity tests.
    de Visser MC; van Hylckama Vlieg A; Tans G; Rosing J; Dahm AE; Sandset PM; Rosendaal FR; Bertina RM
    J Thromb Haemost; 2005 Jul; 3(7):1488-94. PubMed ID: 15978106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis.
    Raffa S; Reverter JC; Seijo S; Tassies D; Abraldes JG; Bosch J; García-Pagán JC
    Clin Gastroenterol Hepatol; 2012 Jan; 10(1):72-8. PubMed ID: 21946303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated Factor XI is Increased in Plasma in Response to Surgical Trauma but not to Recombinant Activated FVII-Induced Thrombin Formation.
    Rühl H; Friemann AM; Reda S; Schwarz N; Winterhagen FI; Berens C; Müller J; Oldenburg J; Pötzsch B
    J Atheroscler Thromb; 2022 Jan; 29(1):82-98. PubMed ID: 33298665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous stasis-induced fibrinolysis prevents thrombosis in mice: role of α2-antiplasmin.
    Singh S; Houng AK; Reed GL
    Blood; 2019 Sep; 134(12):970-978. PubMed ID: 31395599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism.
    Miljic P; Gvozdenov M; Takagi Y; Takagi A; Pruner I; Dragojevic M; Tomic B; Bodrozic J; Kojima T; Radojkovic D; Djordjevic V
    J Thromb Haemost; 2017 Apr; 15(4):670-677. PubMed ID: 28075532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Prothrombin Mutation (Arg596Trp, Prothrombin Padua 2) Associated With Venous Thromboembolism.
    Bulato C; Radu CM; Campello E; Gavasso S; Spiezia L; Tormene D; Simioni P
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1022-9. PubMed ID: 27013614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heightened thrombin generation in individuals with resistance to activated protein C.
    Martinelli I; Bottasso B; Duca F; Faioni E; Mannucci PM
    Thromb Haemost; 1996 May; 75(5):703-5. PubMed ID: 8725708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype.
    Reda S; Schwarz N; Müller J; McRae HL; Oldenburg J; Pötzsch B; Rühl H
    Res Pract Thromb Haemost; 2024 Feb; 8(2):102351. PubMed ID: 38487678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.